| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
phenotype | 0.100 | None | 0.993 | 134 | 0 | 1999 | 2019 | |||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.100 | None | 0.948 | 134 | 1 | 1990 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.100 | None | 0.970 | 133 | 0 | 1992 | 2020 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
phenotype | 0.100 | None | 0.992 | 129 | 1 | 1999 | 2020 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
phenotype | 0.100 | None | 0.968 | 125 | 0 | 1997 | 2020 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
phenotype | 0.400 | None | 0.975 | 118 | 1 | 2005 | 2020 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
phenotype | 0.100 | None | 0.991 | 107 | 0 | 2006 | 2019 | |||||||||
|
Yes associated protein 1 | 0.432 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0.990 | 98 | 0 | 2007 | 2020 | ||||||||
|
GA binding protein transcription factor subunit alpha | 0.379 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.979 | 97 | 0 | 2005 | 2020 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.884 | 95 | 1 | 1987 | 2020 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
phenotype | 0.100 | None | 0.989 | 94 | 2 | 1990 | 2019 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0.989 | 94 | 0 | 1996 | 2020 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
phenotype | 0.100 | None | 0.926 | 94 | 1 | 1996 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.100 | None | 0.989 | 92 | 1 | 1989 | 2020 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
phenotype | 0.100 | None | 0.989 | 91 | 0 | 1994 | 2020 | ||||||||
|
sirtuin 1 | 0.378 | 0.885 | 8.7E-02 |
|
phenotype | 0.100 | None | 1.000 | 90 | 0 | 2005 | 2020 | ||||||||
|
menin 1 | 0.444 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0.922 | 90 | 0 | 1991 | 2020 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
phenotype | 0.100 | None | 0.977 | 87 | 0 | 1990 | 2019 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 82 | 1 | 1994 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
phenotype | 0.100 | None | 0.936 | 78 | 2 | 1985 | 2018 | ||||||||
|
fragile histidine triad diadenosine triphosphatase | 0.444 | 0.846 | 5.7E-03 |
|
phenotype | 0.100 | None | 0.947 | 76 | 0 | 1996 | 2019 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
phenotype | 0.100 | None | 0.960 | 75 | 3 | 1997 | 2019 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
phenotype | 0.100 | None | 0.987 | 75 | 1 | 1994 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 74 | 1 | 1991 | 2020 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
phenotype | 0.100 | None | 0.973 | 73 | 2 | 1999 | 2019 |